Literature DB >> 27269739

Immunotherapy for small-cell lung cancer.

Yangqiu Li1, Yi-Long Wu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27269739     DOI： 10.1016/S1470-2045(16)30159-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Comparing strategy of immune checkpoint inhibitors plus chemotherapy with chemotherapy alone for small cell lung cancer: a meta-analysis based on six RCTs incorporating 2800 participants.

Authors:  Yaqi Zhong; Qing Wu; Sumei Wu; Xianhe Xie
Journal:  J Cancer Res Clin Oncol       Date:  2021-09-17       Impact factor: 4.322

Review 2.  Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China.

Authors:  Si-Yang Liu; Yi-Long Wu
Journal:  J Hematol Oncol       Date:  2017-07-05       Impact factor: 17.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.